Can You Calculate Cavitation Treatment Depth from kHz Alone?
Ultrasound · Specifications explained
No: a 40K or 80K label does not give you a validated treatment depth.
Short answer: You cannot calculate a reliable cavitation treatment depth from kHz alone. Frequency is one part of an acoustic exposure; the applicator’s field, output, tissue path and intended effect also matter. A wave reaching a depth is not proof that fat changes there, or that neighboring tissue is safe. Treat a 40K/80K depth chart as an unverified claim unless it defines “depth” and supplies matching device-specific measurements and evidence. Do not use it to select treatment areas or settings. [1] [2]
First, separate three meanings of “depth”
A brochure can use one word for three different claims. Before comparing numbers, ask what was measured and what the measurement is supposed to establish.
On a phone, scroll each table sideways to read its final column.
| Meaning | Question it answers | What it does not prove |
|---|---|---|
| Acoustic reach | Is sound detectable at a stated distance, under defined test conditions? | That the exposure produces a useful tissue effect there. |
| Target or focal location | Where does the device concentrate its field, if it is focused? | That every tissue along or beyond the beam path is unaffected. |
| Verified effect depth | Where was a defined tissue change actually demonstrated? | That another machine, body site or person will have the same result. |
This distinction follows the separate questions in FDA’s guidance for focused aesthetic ultrasound systems: characterize the beam, establish delivery to the target, demonstrate the intended tissue effect, and assess non-target tissues. That guidance is indirect context for low-frequency nonfocused machines, not evidence that they meet those requirements. [1]
Wavelength is not treatment depth
Wavelength describes the spacing of a repeating sound wave in a medium. It does not identify a boundary where treatment starts or stops. Even a correct wavelength calculation supplies no measurement of the pressure field, tissue response or safety beyond a target. Converting that spacing into “centimeters of fat treated” substitutes a different quantity for the claim that needs testing.
A depth value also needs a reference point: from the skin surface, the applicator face, or another defined plane? Without that origin and a stated endpoint, two depth figures are not meaningfully comparable.
Why the acoustic field and tissue path matter
The acoustic field is the distribution of sound pressure through space and time. A frequency label does not describe that distribution. The transducer and focusing arrangement shape the field, while output and waveform describe the exposure. NPL’s therapeutic-ultrasound work uses field characterization, modeling and material measurements together to assess acoustic and thermal dose. [2]
Sound propagation is not a fixed treatment zone
Attenuation describes the reduction of an acoustic signal during propagation. Tissue is not a uniform block: its acoustic properties affect the path. NPL’s imaging research maps tissue sound speed, attenuation and stiffness and describes beam distortion during propagation through breast tissue. That is a measurement example, not body-contouring efficacy evidence. [3]
Consequently, a water-tank field map is a result for its stated test environment. It needs a justified tissue model or other relevant validation before it supports a tissue-depth claim. A drawing of a beam crossing a fat layer is not that validation.
Cavitation activity and tissue response are separate questions
Bubble behavior depends on experimental conditions. A histotripsy study tested mechanically adjustable agarose phantoms and found that stiffness and frequency affected bubble expansion. Histotripsy uses focused ultrasound for mechanical tissue disruption; this experiment does not establish a depth or fat-reduction result for a nonfocused 40K/80K device. Only the abstract was reviewed. [4]
The practical implication is to request evidence for the proposed effect in the relevant material or tissue. Neither a bubble observation nor an acoustic measurement alone establishes a visible body-contouring outcome.
How to evaluate an advertised 40K/80K depth table
Start with the report behind the table. The following is a depth-claim audit, not a home experiment or a regulatory certification checklist.
| Check | Ask for | If missing |
|---|---|---|
| Depth endpoint | Detection threshold, focal location or demonstrated tissue effect; measurement origin and units. | The number has no clear interpretation. |
| Exact field | Identified model and applicator, focusing status, mode and spatial field measurements. | The frequency category cannot fill the gap. |
| Test environment | Water, phantom, isolated tissue or living tissue; material properties and any tissue correction. | The result cannot simply be relabeled as human depth. |
| Effect and boundaries | Evidence locating the claimed response and assessing adjacent, shallower and deeper tissues. | A safe treatment zone is not established. |
| Measurement reliability | Method, calibration, uncertainty, tested conditions and variability between units. | Apparent precision exceeds the documented evidence. |
FDA’s focused-system guidance specifically separates acoustic power, beam targeting, thermal effects and possible cavitation, and calls for assessment of tissue outside the target. It illustrates the missing questions; it does not supply answers for an unnamed low-frequency machine. [1]
A useful document request: “What does your stated depth measure, and from which reference plane? Please provide the report for this exact ultrasound applicator, including the field map, test medium, operating mode, uncertainty, and evidence supporting the claimed tissue effect and non-target tissue safety.”
Keep physics claims separate from outcome claims
A measured pressure distribution answers a physics question. “Reduces fat at this depth” needs biological and clinical evidence relevant to that claim. A waist measurement or before-and-after photograph does not reveal the location of a tissue effect. Likewise, a deeper detected signal does not establish a better cosmetic result.
For example, FDA record K100874 describes the LipoSonix System Model 1, a focused system using thermal coagulation and cellular disruption for non-invasive waist circumference reduction. Its device-specific targeting and evidence cannot be converted into a generic 40K/80K depth chart or home-use claim. [5] Keep low-frequency nonfocused cavitation, focused mechanical ultrasound, thermal high-intensity focused ultrasound (HIFU), 1 MHz systems and radiofrequency (RF) attachments in their own evidence categories.
Three errors that make depth claims misleading
- Giving every machine with the same kHz label the same depth. A shared frequency does not provide a shared field map.
- Treating a depth range as a sharp safety boundary. A claimed target region does not demonstrate absence of exposure or injury outside it.
- Using a depth figure to approve a body area. Anatomy, the intended use and the exact device’s safety documentation still require assessment.
If the source documents do not define and validate the endpoint, record the depth as not established. Do not turn a general acoustic explanation into a precise table.
Safety: a depth chart cannot clear you for treatment
FDA’s US body-contouring guidance identifies burns and nerve damage among ultrasound-related risks. It advises against ultrasound procedures with open wounds, compromised skin, active implants such as pacemakers, or metal beneath the skin. These are technology-level cautions, not a complete screening list or proof of authorization for a particular machine. [6]
Follow the current instructions for the exact device and seek a qualified healthcare professional’s suitability assessment, especially where pregnancy, breastfeeding, illness, implants or prior procedures raise questions. Missing depth data is not a reason to test the boundary on your own skin. Stop use and seek medical assessment for burning, blistering, significant pain, numbness or another unexpected reaction.
No universal energy setting, session duration, treatment frequency or body-area protocol is provided here. Do not increase output or extend exposure to try to reach a brochure’s claimed depth.
Frequently asked questions
What if a depth chart gives a range rather than one number?
A range still needs a defined endpoint, origin, test method and applicable conditions. It could describe field spread, variation in a test or a tissue-effect zone; those meanings are different. A range alone does not resolve the evidence gap.
Can a pinch test verify the machine’s depth?
No. A pinch does not map acoustic pressure or show where a tissue effect occurs. It cannot replace the device’s intended-use requirements, anatomical assessment or matched safety evidence.
Does an imaging scan before treatment prove the advertised depth?
An anatomical measurement and an acoustic field measurement answer different questions. Imaging can document tissue thickness under its own method, but that alone does not validate the treatment applicator’s field or the claimed effect. Ask how the anatomical information is connected to the exact device’s validated targeting method.
What to do with an unsupported depth claim
Keep the frequency label as a specification and leave treatment depth unresolved. Request the report that defines the depth and validates the intended effect. If only a generic chart is available, it is insufficient for choosing a treatment area, predicting a result or judging personal safety.
Sources and scope
- FDA: Focused Ultrasound Stimulator System for Aesthetic Use — special controls guidance. Official text reviewed; focused systems only.
- NPL: Therapeutic ultrasound. Official measurement research overview; not a low-frequency beauty-device test report.
- NPL: Quantitative imaging. Tissue acoustic-property and beam-distortion context; no contouring outcome.
- Vlaisavljevich et al. (2015): Effects of tissue stiffness, ultrasound frequency, and pressure on histotripsy-induced cavitation bubble behavior. Abstract reviewed; full text not verified. Phantom experiment, not 40K/80K consumer evidence.
- FDA K100874: LipoSonix System Model 1. Seven-page record reviewed; specific thermal focused system.
- FDA: Non-Invasive Body Contouring Technologies. Ultrasound safety section reviewed; US consumer context.
This article is for general educational purposes and does not provide medical advice. Follow the instructions for the specific device and consult a qualified healthcare professional about suitability and safety.